As of 2025-07-05, the Relative Valuation of Mirati Therapeutics Inc (MRTX) is (135.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.70 USD, the upside of Mirati Therapeutics Inc based on Relative Valuation is -330.5%.
The range of the Relative Valuation is (135.55) - (141.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 13.7x | 13.4x |
| Forward P/E multiples | 11.8x - 13.7x | 12.8x |
| Fair Price | (135.55) - (141.76) | (135.29) |
| Upside | -330.9% - -341.5% | -330.5% |
| Date | P/E |